SG10201504871PA - Methods of treating conditions associated with overactive bladder - Google Patents
Methods of treating conditions associated with overactive bladderInfo
- Publication number
- SG10201504871PA SG10201504871PA SG10201504871PA SG10201504871PA SG10201504871PA SG 10201504871P A SG10201504871P A SG 10201504871PA SG 10201504871P A SG10201504871P A SG 10201504871PA SG 10201504871P A SG10201504871P A SG 10201504871PA SG 10201504871P A SG10201504871P A SG 10201504871PA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- conditions associated
- treating conditions
- overactive bladder
- overactive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/48—Devices for preventing wetting or pollution of the bed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Environmental & Geological Engineering (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Microscoopes, Condenser (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35732110P | 2010-06-22 | 2010-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201504871PA true SG10201504871PA (en) | 2015-07-30 |
Family
ID=45372075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012095246A SG186815A1 (en) | 2010-06-22 | 2011-06-22 | Methods of treating conditions associated with overactive bladder |
SG10201504871PA SG10201504871PA (en) | 2010-06-22 | 2011-06-22 | Methods of treating conditions associated with overactive bladder |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012095246A SG186815A1 (en) | 2010-06-22 | 2011-06-22 | Methods of treating conditions associated with overactive bladder |
Country Status (16)
Country | Link |
---|---|
US (1) | US20120107385A1 (es) |
EP (1) | EP2585010A4 (es) |
JP (1) | JP2013534923A (es) |
KR (1) | KR20130118296A (es) |
CN (1) | CN103153245A (es) |
AR (1) | AR084700A1 (es) |
AU (1) | AU2011270995A1 (es) |
CA (1) | CA2803872A1 (es) |
CL (2) | CL2012003658A1 (es) |
EA (1) | EA201291299A1 (es) |
MX (1) | MX2013000002A (es) |
PE (1) | PE20130639A1 (es) |
SG (2) | SG186815A1 (es) |
TW (1) | TW201212910A (es) |
WO (1) | WO2011163356A2 (es) |
ZA (1) | ZA201209757B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6856380B2 (ja) | 2014-06-26 | 2021-04-07 | タリス バイオメディカル エルエルシー | 弾性ポリマー−薬物マトリックス系を含む膀胱内薬物送達デバイス及び方法 |
CN112839653A (zh) * | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
WO2022225379A1 (ko) * | 2021-04-23 | 2022-10-27 | 김승범 | 과민성 방광 치료 장치 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
DE69929055T2 (de) * | 1998-05-01 | 2006-07-20 | Duramed Pharmaceuticals Inc., Cincinnati | Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung |
US6436428B1 (en) * | 2000-03-21 | 2002-08-20 | Enhance Pharmaceuticals, Inc. | Device and method for treating urinary incontinence in females |
JP2005513080A (ja) * | 2001-12-20 | 2005-05-12 | フェムファーマ, インコーポレイテッド | 薬物の膣送達 |
US7005138B2 (en) * | 2001-12-21 | 2006-02-28 | Duramed Pharmaceuticals, Inc. | Method of systematically delivering SSRIs |
CN1822815B (zh) * | 2003-07-10 | 2012-04-11 | 沃纳奇尔科特(爱尔兰)有限公司 | 阴道内药物传递装置 |
CA2596933A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
-
2001
- 2001-07-27 MX MX2013000002A patent/MX2013000002A/es not_active Application Discontinuation
-
2011
- 2011-06-22 AU AU2011270995A patent/AU2011270995A1/en not_active Abandoned
- 2011-06-22 AR ARP110102163A patent/AR084700A1/es unknown
- 2011-06-22 EP EP11798840.2A patent/EP2585010A4/en not_active Withdrawn
- 2011-06-22 KR KR1020137001335A patent/KR20130118296A/ko not_active Application Discontinuation
- 2011-06-22 WO PCT/US2011/041444 patent/WO2011163356A2/en active Application Filing
- 2011-06-22 PE PE2012002492A patent/PE20130639A1/es not_active Application Discontinuation
- 2011-06-22 CA CA2803872A patent/CA2803872A1/en not_active Abandoned
- 2011-06-22 SG SG2012095246A patent/SG186815A1/en unknown
- 2011-06-22 US US13/166,302 patent/US20120107385A1/en not_active Abandoned
- 2011-06-22 CN CN2011800313890A patent/CN103153245A/zh active Pending
- 2011-06-22 EA EA201291299A patent/EA201291299A1/ru unknown
- 2011-06-22 TW TW100121861A patent/TW201212910A/zh unknown
- 2011-06-22 SG SG10201504871PA patent/SG10201504871PA/en unknown
- 2011-06-22 JP JP2013516731A patent/JP2013534923A/ja active Pending
-
2012
- 2012-12-21 ZA ZA2012/09757A patent/ZA201209757B/en unknown
- 2012-12-21 CL CL2012003658A patent/CL2012003658A1/es unknown
-
2013
- 2013-12-05 CL CL2013003488A patent/CL2013003488A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011163356A2 (en) | 2011-12-29 |
CL2013003488A1 (es) | 2014-08-08 |
WO2011163356A3 (en) | 2012-03-22 |
TW201212910A (en) | 2012-04-01 |
PE20130639A1 (es) | 2013-06-15 |
AU2011270995A1 (en) | 2013-01-10 |
KR20130118296A (ko) | 2013-10-29 |
CA2803872A1 (en) | 2011-12-29 |
AR084700A1 (es) | 2013-06-05 |
US20120107385A1 (en) | 2012-05-03 |
ZA201209757B (en) | 2015-06-24 |
EA201291299A1 (ru) | 2013-09-30 |
CN103153245A (zh) | 2013-06-12 |
SG186815A1 (en) | 2013-02-28 |
CL2012003658A1 (es) | 2014-02-14 |
EP2585010A4 (en) | 2014-10-01 |
EP2585010A2 (en) | 2013-05-01 |
JP2013534923A (ja) | 2013-09-09 |
MX2013000002A (es) | 2013-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL226401A0 (en) | Methods for treating disorders related to @fgfBA | |
ZA201208815B (en) | Methods of treating bladder cancer | |
ZA201304280B (en) | Treatment of jak2-mediated conditions | |
EP2723384A4 (en) | TREATMENT OF PROTEINOPATHIES | |
EP2611496A4 (en) | Methods of Treatment | |
EP2717855A4 (en) | PROCESSING METHODS | |
PL3581199T3 (pl) | Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej | |
GB201018147D0 (en) | Method of treatment | |
IL230433A0 (en) | Pain management methods | |
EP2701694A4 (en) | METHOD FOR THE TREATMENT OF HEMOGLOBINOPATHIES | |
IL256026B (en) | Treatment methods | |
HK1179823A1 (en) | Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10- | |
HK1199616A1 (en) | Cachexia treatment | |
GB201003920D0 (en) | Method of treatment | |
ZA201403739B (en) | Methods of treatment with deferiprone | |
ZA201309109B (en) | Methods of treating biomass | |
ZA201209757B (en) | Methods of treating conditions associated with overactive bladder | |
EP2585103A4 (en) | METHOD OF TREATMENT | |
GB201018149D0 (en) | Method of treatment | |
GB201020015D0 (en) | Method of treatment | |
GB201110602D0 (en) | Methods of treatment | |
GB201109737D0 (en) | Methods of treatment | |
GB201005071D0 (en) | Method of treatment | |
GB201003917D0 (en) | Method of treatment | |
GB201000318D0 (en) | Method of treatment |